TITLE

Celgene Reports 1st Qtr 2012 Operating and Financial Results

PUB. DATE
April 2012
SOURCE
Biomedical Market Newsletter;4/28/2012, Vol. 21, p1
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article provides information on the financial results of Celgene Corp. for the first quarter ended March 31, 2012. It indicates that non-GAAP net product sales for the first quarter of 2012 were 1,245 million U.S. dollars compared. The company also reported net income of 484 million dollars in the first quarter of 2012 and nonGAAP diluted earnings per share of 1.08 dollars. Celgene will host a conference call to discuss the first quarter 2012 financial performance on April 26, 2012.
ACCESSION #
76119582

 

Related Articles

  • Celgene Reports 2nd Quarter 2012 Operating and Financial Results.  // Biomedical Market Newsletter;7/26/2012, Vol. 21, p1 

    The article informs that Celgene Corp. has reported results for the 2nd quarter of 2012. It mentions that total revenue for the 2nd quarter of 2012 was 1,367 million U.S. dollars, a 16 percent increase from the same period in 2011. It also informs that non-generally accepted accounting...

  • Thermo Fisher Scientific Reports 2nd Quarter 2012 Results.  // Biomedical Market Newsletter;7/26/2012, Vol. 21, p1 

    The article informs that Thermo Fisher Scientific Inc. has reported its financial results for the 2nd quarter ended June 30, 2012. It mentions that adjusted earnings per share have increased to a 2nd quarter record of 1.22 U.S. dollars while the revenue increased to the same period record of...

  • HMS Holdings Corp Reports 1st Qtr 2012 Results.  // Biomedical Market Newsletter;4/28/2012, Vol. 21, p1 

    The article provides information on the financial results of HMS Holdings Corp. for the first quarter ended March 31, 2012. It indicates that total revenue for the first quarter of 2012 was 107.3 million U.S. dollars compared to 82.5 million dollars in same period during 2011. The company also...

  • HMS Holdings Corp. Announces 2nd Quarter 2012 Financial and Operating Results.  // Biomedical Market Newsletter;8/7/2012, Vol. 21, p1 

    The article offers information on the release of financial results by HMS Holdings Corp. for second quarter of 2012. The revenues generated by the company increased by 34.4 percent with total of 120.1 million dollars. The company earned operating income of 13 million dollars with rise in diluted...

  • RTI Biologics Announces 2012 1st Qtr Results.  // Biomedical Market Newsletter;4/28/2012, Vol. 21, p1 

    The article provides information on the financial results of RTI Biologics Inc. for the first quarter ended March 31, 2012. It indicates that total revenue for the first quarter of 2012 was 43.7 million U.S. dollars and the net income was two million dollars. The company also reported quarterly...

  • BioClinica Reports 14.9% Growth in 1st Qtr Service Revenues.  // Biomedical Market Newsletter;5/12/2012, Vol. 21, p1 

    The article provides information on the financial results of BioClinica Inc. for the first quarter ended March 31, 2012. It indicates that the service revenues increased 14.9 percent to 18.6 million U.S. dollars as compared with 16.1 million dollars for the same period 2011. While the non-GAAP...

  • Healthy living pays fat dividend for NBTY as shares more than double in a year.  // Crain's New York Business;11/20/2006, Vol. 22 Issue 47, p4 

    The article states that nutritional supplement maker, distributor and marketer NBTY Inc. in November 2006 reported a quarterly profit of 54 cents a share, beating Wall Street forecasts by 35%. The earnings helped send the company's stock up 17%, pushing the year-to-date gain to over 100%. The...

  • Pall Corp Reports Third Quarter Results.  // Biomedical Market Newsletter;6/7/2012, Vol. 21, p1 

    The article informs that Pall Corp. has released its financial results for the third quarter of fiscal year 2012 ended April 30, 2012 along with corporate highlights. It informs that the third quarter sales reported an increase of one percent with diluted earning per share (EPS) being 0.67 U.S....

  • Forest Laboratories Inc. Reports FY 4th Qtr 2012 Earnings Per Share of $0.72 Including $0.06 Per Share of Acquisition Amortization.  // Biomedical Market Newsletter;4/21/2012, Vol. 21, p1 

    The article provides information on the financial results of Forest Laboratories Inc. for the fourth quarter of 2012. It indicates that earnings per share equaled 0.72 U.S. dollar in the fourth quarter of fiscal year 2012 compared to 1.12 dollar in 2011. The company also reported net sales of...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics